This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest
![](https://aptar.com/wp-content/uploads/2024/03/Thumbnail_Webinar_InSilicoModelling_2024-1024x665.jpg)
In Silico Modelling for Orally Inhaled Drug Development (OINDP)
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2022/04/ConversationsWithAnAptarPharmaExpert.jpg)
Sustainable Propellants and Bioequivalence Innovation in OINDPs
Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2023/12/ONDD_Dec2023.jpg)
Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2023/12/Thumbnail_Webinar_NanopharmGMP_2023-1024x665.jpg)
Advancing Inhaled & Nasal Drug Clinical Studies: Insights & Strategies
Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions